Aprea Therapeutics, Inc. (APRE)
$0.81+26.56%Close
BUYRECOVERY · day 12
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $5M
- Avg volume
- 122.7K
- Beta
- 1.59
- P/E (TTM)
- -0.62
- Short % float
- 0.85%
- Days to cover
- 1.0
- SI change
- -32.2%
- 1W
- +17.39%
- 1M
- +28.57%
- 3M
- -14.74%
- YTD
- -4.71%
- vs SPY 1W
- +18.58%
- vs SPY 1M
- +25.25%
- vs SPY 3M
- -17.13%
- vs SPY YTD
- -16.46%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- DCTHSELLDelcath Systems, Inc.BULLQ -25$16.75-2.28%
- AEONSELLAEON Biopharma, Inc.CRISISQ -39$0.20+5.26%
- BFRIBUYBiofrontera Inc.BULLQ -16$1.46-1.35%
- AXGNBUYAxoGen, Inc.BULLQ 16$49.23-2.32%
- ACHVBUYAchieve Life Sciences, Inc.BULLQ -9$7.94-0.63%
- TMCIBUYTreace Medical Concepts, Inc.RECOVERYQ -18$4.37+0.69%
- ACTUBUYActuate Therapeutics IncRECOVERYQ -27$1.23-3.15%
- VNRXSELLVolitionRx LimitedCRISISQ -10$0.39-7.14%
- DRMABUYDermata Therapeutics, Inc.RECOVERYQ -27$1.63+14.79%
- KAPASELLKairos Pharma, Ltd.CRISISQ -23$0.23-20.69%
- BOLDBUYBoundless Bio, Inc.BULLQ -15$2.96-1.33%
- NVCTBUYNuvectis Pharma, Inc.RECOVERYQ 40$23.87+1.32%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 14
- VALUE
- 29
- GROWTH
- 39
- GARP
- 1
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC-28.0%
REV YoY-
ROE-46.7%
EPS YoY-
ROA-29.1%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-0.62
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B1.12
P/FCF-
EV/EBITDA2.54
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO13.55
ND/EBITDA-
BETA1.59
